Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials-Reference-Cited by-同舟云学术

Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials

Published:2013-01-30 Issue:2 Volume:65 Page:309-313
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Hsia Elizabeth C.,Cush John J.,Matteson Eric L.,Beutler Anna,Doyle Mittie K.,Hsu Benjamin,Xu Stephen,Rahman Mahboob U.

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.21788/fullpdf

Reference9 articles.

1. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009;Furst;Ann Rheum Dis,2010

2. Cellestis www.cellestis.com

3. Oxford Immunotec http://www.oxfordimmunotec.com/T-SPOT_International

4. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis;Hsia;Arthritis Rheum,2012

5. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists;Carmona;Arthritis Rheum,2005

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases;Annals of the Rheumatic Diseases;2022-11-03

2. Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases;RMD Open;2022-11

3. Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study;Gut and Liver;2021-12-27

4. Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis;Medicine;2021-09-24

5. Infections in baricitinib clinical trials for patients with active rheumatoid arthritis;Annals of the Rheumatic Diseases;2020-08-11